Mason Street Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-100,972
Closed -$10M 1543
2019
Q3
$10M Buy
100,972
+390
+0.4% +$37.1K 0.21% 85
2019
Q2
$9.3M Buy
100,582
+382
+0.4% +$36.3K 0.19% 91
2019
Q1
$9.45M Buy
100,200
+1,616
+2% +$141K 0.19% 95
2018
Q4
$6.32M Sell
98,584
-294
-0.3% -$21.7K 0.15% 114
2018
Q3
$8.85M Sell
98,878
-293
-0.3% -$25.9K 0.18% 95
2018
Q2
$7.88M Sell
99,171
-5,606
-5% -$465K 0.17% 100
2018
Q1
$9.35M Sell
104,777
-4,890
-4% -$469K 0.21% 84
2017
Q4
$11.4M Buy
109,667
+1,062
+1% +$120K 0.26% 70
2017
Q3
$15.8M Buy
108,605
+235
+0.2% +$32K 0.38% 48
2017
Q2
$14.1M Buy
108,370
+861
+0.8% +$105K 0.35% 46
2017
Q1
$13.4M Buy
107,509
+1,465
+1% +$175K 0.34% 47
2016
Q4
$12.3M Buy
106,044
+1,187
+1% +$132K 0.33% 52
2016
Q3
$11M Buy
104,857
+523
+0.5% +$56.6K 0.31% 55
2016
Q2
$10.3M Buy
104,334
+215
+0.2% +$22.2K 0.3% 60
2016
Q1
$10.4M Buy
104,119
+1,482
+1% +$153K 0.32% 57
2015
Q4
$12.3M Buy
102,637
+352
+0.3% +$40.7K 0.38% 48
2015
Q3
$11.1M Buy
102,285
+156
+0.2% +$19.4K 0.37% 51
2015
Q2
$11.8M Sell
102,129
-975
-0.9% -$111K 0.36% 53
2015
Q1
$11.9M Sell
103,104
-483,250
-82% -$57.7M 0.36% 58
2014
Q4
$65.6M Buy
586,354
+49,052
+9% +$5.17M 0.46% 22
2014
Q3
$50.9M Buy
537,302
+143,453
+36% +$12.9M 0.4% 33
2014
Q2
$33.8M Sell
393,849
-3,373
-0.8% -$257K 0.26% 68
2014
Q1
$27.7M Sell
397,222
-303,478
-43% -$24M 0.22% 96
2013
Q4
$59.2M Buy
700,700
+382,786
+120% +$30.3M 0.48% 24
2013
Q3
$24.5M Sell
317,914
-51,736
-14% -$3.63M 0.28% 78
2013
Q2
$21.6M Buy
+369,650
New +$22.2M 0.24% 105

Other funds holding CELG

Mason Street Advisors's CELG Position: Q4 2019 in Review

Mason Street Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 100,972 shares — an estimated $10M sold.

Mason Street Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $65.6M in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Mason Street Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Mason Street Advisors sold 100,972 Celgene Corp shares in Q4 2019, an estimated $10M.
  • Mason Street Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Mason Street Advisors's Celgene Corp position peaked at $65.6M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Mason Street Advisors's 13F filing for Q4 2019, filed 19 Feb 2020.